# A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet

> **NCT03362411** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BMS-986205

## Key facts

- **NCT ID:** NCT03362411
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-09
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-02-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03362411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03362411, "A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet". Retrieved via MORVS 2026-10-28 from https://api.morvs.ai/clinical/NCT03362411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*